Jasmine Zain, MD
Dr. Jasmine Zain is an Associate Clinical Professor in the Division of Hematology and Oncology, and the Associate Director for the Bone Marrow Transplantation (BMT) Program at the College of Physicians and Surgeons at the New York Presbyterian Hospital, Herbert Irving Comprehensive Cancer Center at Columbia University. She is also an active member of the Center for the Lymphoid Malignancies at Columbia.
Dr. Zain obtained her Medical Doctorate from Fatima Jinnah Medical College for Women in Pakistan, having graduated in 1987. After graduation, she worked as a House Officer in Internal Medicine at the Sir Ganga Ram Hospital in Lahore Pakistan from 1988 to 1989. In 1989 she began a residency in Internal Medicine at North Shore Hospital in New York and went on to complete a fellowship in Hematology and Oncology at New York University Medical Center between 1994 and 1999 Following the completion of her fellowship, she worked as a Hematologist-Oncologist and transplant physician at the Brooklyn Hospital Center, until she joined City of Hope National Medical Center as an attending physician in 2002. In 2008, she moved to New York to become an Assistant Clinical Professor at the College of Physicians and Surgeons at the New York Presbyterian Hospital, Herbert Irving Comprehensive Cancer Center at Columbia University. In 2009 she accepted a position to lead and develop the stem cell transplant program at New York University Langone Medical Center that started performing allogeneic stem cell transplants in 2011.
Most recently, Dr. Zain has accepted a position as the Associate Director for Bone Marrow Transplant at Columbia University Medical Center where she is continuing her work in the treatment of lymphoid malignancies and stem cell transplantation. She is board certified in the areas of Internal Medicine, Hematology and Oncology, and has state licenses in California and New York.
Over the last decade, Dr. Zain has come to be regarded as a specialist in T-cell lymphoma, especially in the management of cutaneous T-cell lymphoma. In addition she has world class expertise in the treatment and management of patients who are candidates for stem cell transplantation. During her career, she has worked closely with experts both in the field of lymphoid malignancies and stem cell transplantation giving her a unique niche that traverses both fields. This opportunity allows her to specifically focus on the experimental and transplantation therapies for patients with lymphoma, particularly rare variants like T-cell lymphomas. Her collaborators have included Drs. Stephen Forman and Owen O’ Connor.